Summary of Key Points
GLP-1 class drugs were originally “old medications” used to treat diabetes but became incredibly popular after it was accidentally discovered that they could help with weight loss. They have also shown potential in treating other conditions such as addiction and cardiovascular diseases, however, they come with several risks: the weight regain after stopping the medication is mostly due to fat accumulation, and long-term use may increase the risk of osteoporosis; the market is flooded with unapproved “combinations of GLP-1” products, which lack safety guarantees; Novo Nordisk has received a warning from the FDA for failing to report patient deaths (including suicides) in a timely manner.
Detailed Analysis
1. How Do GLP-1s Become “Weight Loss Miracle Drugs”? – Mimicking Natural Hormones to Control Weight
GLP-1 is a hormone naturally produced by the body with two main functions: it promotes insulin secretion to lower blood sugar (hence its initial use in diabetes treatment) and signals the brain to feel full more quickly and for longer, thereby reducing food intake. The pharmaceutical version of GLP-1 has been modified to resist breakdown by enzymes in the body, allowing effects to last for up to a week with a single injection, which leads to reduced food consumption and weight loss. However, it’s important to note that the weight regained after stopping the medication is primarily fat, resulting in less muscle and more fat, potentially worsening overall health.
2. Combinations of GLP-1: Cheaper but Potentially Risky
Combination drugs are customized by compounding pharmacies to meet specific patient needs (e.g., special dosages or formulations as creams), but they have not undergone FDA safety and efficacy testing. Why are they popular? Original drugs like Wegovy were in short supply, so combination drugs filled this gap. Although the supply of original drugs has increased, combination drugs are cheaper due to lower material costs and flexible dosing options, which is why they are still being sold. However, there are significant issues: some combination drugs contain additives intended to prevent muscle loss or reduce nausea, but these have not been verified and may pose unknown risks.
3. Unexpected Benefits: Could GLP-1 Help with Addiction?
Many people who use GLP-1 report reduced cravings for snacks, as well as decreased desires for tobacco, alcohol, and drugs, and some even stop nail-biting habits. Studies show that the risk of substance addiction (to alcohol, nicotine, opioids, etc.) is reduced by 25%, and in already addicted individuals, the mortality rate decreases by 50% and emergency visits are reduced by 30%. This is because the brain pathways responsible for “food reward” and addiction overlap, and GLP-1 affects both. However, this is still in the early stages of research and cannot be considered a standalone treatment for addiction.
4. Long-Term Use May Lead to Bone Weakness
Research from 2026 indicates that people using GLP-1 have a 30% higher risk of osteoporosis and slightly increased rates of gout and osteomalacia. Possible reasons include rapid weight loss leading to muscle loss, which deprives bones of support and stimulation, as well as the drugs potentially affecting bone metabolism (e.g., reducing bone formation). Long-term users should pay attention to calcium supplementation and regular bone density monitoring.
5. FDA Warning: Pharmaceutical Companies’ Lack of Safety Reporting
Novo Nordisk, the manufacturer of popular GLP-1 drugs like Ozempic/Wegovy, has been warned by the FDA for failing to report three patient deaths (including suicides) within the required 15-day period. The FDA emphasizes that while the deaths were not directly caused by the drugs, the company’s failure to promptly track and report safety information is a serious violation of regulations. This highlights that even “miracle drugs” require careful safety monitoring.
Conclusion
GLP-1s represent a promising treatment option with potential benefits, but they are not a panacea. They can help with weight loss and may have therapeutic effects on addiction, yet there are risks associated with weight regain after discontinuation, long-term bone health issues, and the use of unapproved combination drugs. Always consult a doctor before using GLP-1s and avoid purchasing cheaper, unapproved combinations.